← Scroll for more →
Financial Statements — NCT
Balance Sheet
(in millions USD)| Metric | Q4 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 |
|---|---|---|---|---|---|
| Cash & Equivalents | 3.40 | 4.04 | -- | 4.91 | 4.91 |
| Short-term Investments | -- | 10.30 | -- | -- | -- |
| Accounts Receivable | 0.27 | 0.29 | -- | 0.26 | -- |
| Total Current Assets | 7.15 | 12.65 | -- | 5.98 | -- |
| Property, Plant & Equipment | 0.04 | 0.05 | -- | 0.01 | -- |
| Total Non-current Assets | 48.21 | 50.56 | -- | 57.31 | -- |
| Total Assets | 55.37 | 63.21 | -- | 63.29 | -- |
| Accounts Payable | 1.04 | 0.85 | -- | 1.05 | -- |
| Short-term Debt | -- | -- | 2.17 | -- | -- |
| Total Current Liabilities | 29.70 | 28.82 | -- | 35.74 | -- |
| Long-term Debt | 1.29 | 2.10 | -- | 3.71 | -- |
| Total Non-current Liabilities | 7.89 | 9.81 | -- | 14.37 | -- |
| Total Liabilities | 37.59 | 38.63 | -- | 50.11 | -- |
| Retained Earnings | 1.70 | 9.69 | -- | 10.16 | -- |
| Total Stockholder Equity | 17.78 | 24.59 | -- | 13.18 | -- |
← Scroll for more columns →
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2025 |
|---|---|
| Total Revenue | 13.39 |
| Cost of Revenue | 9.56 |
| Gross Profit | 3.82 |
| Research & Development | 0.44 |
| Selling, General & Admin | 1.26 |
| Total Operating Expenses | 1.70 |
| Operating Income | 2.12 |
| Pretax Income | 0.90 |
| Net Income | 0.90 |
| Basic EPS | 2.50 |
| Diluted EPS | 2.50 |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2025 |
|---|---|
| Operating Cash Flow | 3.18 |
| Capital Expenditures | 0.55 |
| Free Cash Flow* | 2.64 |
| Investing Cash Flow | (0.55) |
| Financing Cash Flow | (1.48) |
← Scroll for more columns →
* Derived from reported values